CIPLA MEDPRO SOUTH AFRICA LIMITED - Trading Statement

Trading Statement

CIPLA MEDPRO SOUTH AFRICA LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(ISIN Number: ZAE000128179 Share Code: CMP)
("Cipla Medpro" or "the Company")


TRADING STATEMENT

In terms of the JSE Limited Listings Requirements, companies are required to publish a trading
statement as soon as they are reasonably certain that the financial results for the current reporting
period will be more than 20% different from those of the previous corresponding period.

Accordingly, shareholders are advised that the Company expects earnings per share and headline
earnings per share for the 12 months ended 31 December 2012 to be more than 20% lower than
those of the prior comparative period.

Once the Company has certainty on the range of the decrease, a further trading statement will be
released.

The information in this trading statement has not been reviewed or reported on by Cipla Medpro's
auditors. The Company's results for the 12 months ended 31 December 2012 are expected to be
published on or about 26 March 2013.



7 March 2013
Durban

Sponsor
Nedbank Capital

Date: 07/03/2013 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.